Loading articles...
Spatial transcriptomics reveals distinct molecular signatures in the substantia nigra of Parkinson's disease versus multiple system atrophy (MSA-P) patients, offering a path toward improved diagnostic precision. These patterns may allow clinicians to differ...
Parkinson's disease and multiple system atrophy (MSA) can be difficult to distinguish clinically, leading to delayed or inappropriate treatment. A new spatial transcriptomics study offers a high-resolution view of gene expression patterns in the substantia ...